New guidance on an old problem: Management of intrapartum fetal heart rate tracings

Article

The publication of the National Institute of Child and Health and Human Development recommendations for fetal heart rate interpretation in 1997 brought a major shift in the approach to intrapartum monitoring by standardizing the reading, analysis, and documentation of FHR and uterine contraction tracings.

Implementing the new guidelines

In contrast, developing precise management paradigms for patients falling into the 3 new NICHD categories was difficult, and on that subject the NICHD report was largely silent. Particularly challenging was developing a cogent management scheme for category II tracings, as well as how to deal with tachysystole during labor induction without having to resort to constant "on again, off again" cycles of oxytocin administration. A new practice bulletin from ACOG (with input from the American College of Nurse Midwives and AWHONN) helps fill this void.6

Managing category II tracings

Management of category I and III tracings was never much in doubt. A category I tracing, by definition, is reassuring and demands no specific interventions. Conversely, a category III tracing requires immediate intrauterine resuscitation (eg, maternal repositioning, administration of oxygen and additional intravenous fluids, stopping uterotonics, and consideration of short-term tocolysis), and, if there is not a timely resolution, expedited delivery. What is notable about the new ACOG recommendation for managing category III tracings, however, is that before intrauterine resuscitation, the first step should be to prepare for delivery. That is, one should anticipate the likelihood of needing an expeditious delivery and preemptively remove the common barriers to emergent delivery present on almost all units to facilitate swift action.

The problem with the NICHD categories lay mainly with category II tracings, which account for most intrapartum FHR tracings and have diverse etiologies and prognoses. Indeed, all category II tracings should not be treated equally because there is a broad spectrum of tracing types between category I and category III. The new ACOG practice bulletin for FHR management acknowledges this variability in acuity for category II tracings, although the general recommendation is that these tracings need continued surveillance and reevaluation.

Recent Videos
Dr. Somi Javaid provides advice for sexual health care | Image Credit: hermd.com.
Efficacy found from biopsychosocial approach to women’s sexual health | Image Credit: hermd.com.
Dr. Somi Javaid highlights disparities in sexual health | Image Credit: hermd.com.
How advancements in IVF are impacting embryologist workload and patient care | Image Credit: fertility.coopersurgical.com/our_experts
Study finds no causal link between maternal health in pregnancy and autism risk | Image Credit: med.nyu.edu/faculty.
Mirvie's RNA platform revolutionizes detection of fetal growth restriction | Image Credit: wexnermedical.osu.edu
How early genetic testing empowers parents and improves outcomes | Image Credit: tuftsmedicine.org
Dallas Reed highlights trends and barriers in prenatal genetic testing | Image Credit: tuftsmedicine.org
How maternal fetal medicine specialists improve outcomes for high-risk pregnancies | Image Credit: profiles.mountsinai.org
How the cobas liat assay panels improve STI detection | Image Credit: labqualityconfab.
Related Content
© 2025 MJH Life Sciences

All rights reserved.